Ocugen Correlations
| OCGN Stock | USD 1.28 0.10 8.47% |
The correlation of Ocugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocugen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between Ocugen Inc and NYA is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ocugen Inc and NYA in the same portfolio, assuming nothing else is changed.
Ocugen |
The ability to find closely correlated positions to Ocugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocugen Inc to buy it.
Moving together with Ocugen Stock
| 0.61 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.77 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.61 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
| 0.73 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.77 | HCWB | HCW Biologics | PairCorr |
| 0.77 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
Moving against Ocugen Stock
| 0.59 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.7 | MOLN | Molecular Partners Financial Report 10th of May 2024 | PairCorr |
| 0.59 | BNTX | BioNTech SE Financial Report 13th of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ocugen Stock performing well and Ocugen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ocugen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VXRT | 3.66 | (0.17) | 0.00 | (0.04) | 0.00 | 7.58 | 32.91 | |||
| NVAX | 3.67 | (0.11) | 0.02 | 0.05 | 5.33 | 9.11 | 49.36 | |||
| CWBR | 4.16 | (1.83) | 0.00 | (1.17) | 0.00 | 6.67 | 60.37 | |||
| RAIN | 1.53 | 0.23 | 0.06 | (0.86) | 1.78 | 4.76 | 9.93 | |||
| OCEA | 12.12 | 3.19 | 0.38 | 1.05 | 7.38 | 28.92 | 208.65 | |||
| ELEV | 4.78 | 0.62 | 0.16 | 0.43 | 3.98 | 13.28 | 38.12 | |||
| AVRO | 1.63 | (0.07) | 0.00 | 0.20 | 0.00 | 3.03 | 19.09 | |||
| ZURA | 5.08 | 0.37 | 0.05 | 0.51 | 6.60 | 17.07 | 42.14 | |||
| ENVB | 6.32 | 0.40 | 0.08 | 0.28 | 5.24 | 15.29 | 86.10 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ocugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Ocugen Corporate Management
Elected by the shareholders, the Ocugen's board of directors comprises two types of representatives: Ocugen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ocugen. The board's role is to monitor Ocugen's management team and ensure that shareholders' interests are well served. Ocugen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ocugen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Durgaprasad Annavajjula | Head VP | Profile | |
| CPA CPA | Sr Officer | Profile | |
| Michael Shine | VP Commercial | Profile | |
| Michael MBA | Senior Commercial | Profile | |
| Arun Upadhyay | Chief Development | Profile | |
| Uday Kompella | Cofounder Director | Profile |
Already Invested in Ocugen Inc?
The danger of trading Ocugen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ocugen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ocugen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ocugen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Ocugen Stock analysis
When running Ocugen's price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share 0.025 | Quarterly Revenue Growth 1.426 | Return On Assets (0.47) | Return On Equity (1.10) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.